437 related articles for article (PubMed ID: 7938926)
1. Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness.
Simberkoff MS
Semin Respir Infect; 1993 Dec; 8(4):294-9. PubMed ID: 7938926
[TBL] [Abstract][Full Text] [Related]
2. Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness.
Fedson DS
Semin Respir Infect; 1993 Dec; 8(4):285-93. PubMed ID: 7938925
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal vaccination.
Williams RM
Lippincotts Prim Care Pract; 1998; 2(6):625-33. PubMed ID: 9883157
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
[TBL] [Abstract][Full Text] [Related]
5. [Bacteremic pneumococcal pneumonia].
Pineda Solas V; Pérez Benito A; Domingo Puiggros M; Larramona Carrera H; Segura Porta F; Fontanals Aymerich D
An Esp Pediatr; 2002 Nov; 57(5):408-13. PubMed ID: 12467543
[TBL] [Abstract][Full Text] [Related]
6. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study.
Vila-Corcoles A; Salsench E; Rodriguez-Blanco T; Ochoa-Gondar O; de Diego C; Valdivieso A; Hospital I; Gomez-Bertomeu F; Raga X
Vaccine; 2009 Mar; 27(10):1504-10. PubMed ID: 19171174
[TBL] [Abstract][Full Text] [Related]
7. Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study.
Farr BM; Johnston BL; Cobb DK; Fisch MJ; Germanson TP; Adal KA; Anglim AM
Arch Intern Med; 1995 Nov; 155(21):2336-40. PubMed ID: 7487259
[TBL] [Abstract][Full Text] [Related]
8. An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting.
Mangtani P; Roberts JA; Hall AJ; Cutts FT
Int J Epidemiol; 2005 Jun; 34(3):565-74. PubMed ID: 15764694
[TBL] [Abstract][Full Text] [Related]
9. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
Isaacman DJ; Strutton DR; Kalpas EA; Horowicz-Mehler N; Stern LS; Casciano R; Ciuryla V
Clin Ther; 2008 Feb; 30(2):341-57. PubMed ID: 18343273
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF
Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
[TBL] [Abstract][Full Text] [Related]
11. The pneumococcal conjugate vaccine.
Jacobson RM; Poland GA
Minerva Pediatr; 2002 Aug; 54(4):295-303. PubMed ID: 12131865
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of community-acquired pneumonia in adults].
Barros M M; Cartagena S C; Bavestrello F L
Rev Chilena Infectol; 2005; 22 Suppl 1():s67-74. PubMed ID: 16163421
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan.
Kawakami K; Ohkusa Y; Kuroki R; Tanaka T; Koyama K; Harada Y; Iwanaga K; Yamaryo T; Oishi K
Vaccine; 2010 Oct; 28(43):7063-9. PubMed ID: 20723631
[TBL] [Abstract][Full Text] [Related]
14. Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged > or =65 years in the Netherlands.
Rozenbaum MH; Hak E; van der Werf TS; Postma MJ
Clin Ther; 2010 Aug; 32(8):1517-32. PubMed ID: 20728764
[TBL] [Abstract][Full Text] [Related]
15. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
Albrich WC; Baughman W; Schmotzer B; Farley MM
Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400
[TBL] [Abstract][Full Text] [Related]
16. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.
Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of vaccination against pneumococcal pneumonia.
Willems JS; Sanders CR; Riddiough MA; Bell JC
N Engl J Med; 1980 Sep; 303(10):553-9. PubMed ID: 6772950
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal disease in United States children: prevalence and treatment.
Clanton M
Int J Clin Pract Suppl; 2001 Feb; (118):13-21. PubMed ID: 11715359
[TBL] [Abstract][Full Text] [Related]
19. Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: benefit due to influenza and pneumococcal vaccination not demonstrated.
Skull SA; Andrews RM; Byrnes GB; Kelly HA; Nolan TM; Brown GV; Campbell DA
Vaccine; 2007 Jun; 25(23):4631-40. PubMed ID: 17478015
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal vaccine.
LaForce FM
Semin Respir Infect; 1989 Dec; 4(4):293-8. PubMed ID: 2697052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
